Propranolol is NOT Recommended for ICU Delirium
Propranolol should not be used as a treatment for hyperactive ICU delirium. There is no guideline support or high-quality evidence for this indication, and established alternatives with proven efficacy exist.
Why Propranolol is Inappropriate
Lack of Evidence-Based Support
The 2013 and 2025 SCCM Clinical Practice Guidelines for ICU delirium management make no mention of propranolol as a treatment option 1, 2. The guidelines specifically address:
- Antipsychotics (haloperidol, atypical antipsychotics) - though evidence shows they don't reduce delirium duration 1, 3
- Dexmedetomidine - conditionally recommended over benzodiazepines for sedation in delirious patients (2B recommendation) 1, 2
- Non-pharmacologic interventions - early mobilization (1B recommendation) 1
Limited and Low-Quality Data
Only one small retrospective case series (n=27 episodes) examined propranolol's sedative effects in ICU patients 4. While it showed reduced sedative/analgesic requirements, this was:
- Retrospective and uncontrolled
- Not designed to assess delirium outcomes
- Confounded by concurrent clinical changes
- Never replicated or validated
Safety Concerns in Critical Illness
Propranolol carries significant contraindications highly relevant to ICU patients 5:
- Cardiogenic shock (absolute contraindication)
- Bradycardia and heart blocks (absolute contraindication)
- Bronchospasm risk (contraindicated in asthma)
- Hypotension - can worsen hemodynamic instability
- Masks hypoglycemia - dangerous in critically ill patients
- Drug interactions - extensive CYP450 interactions with common ICU medications 5
What TO Use Instead
For Hyperactive Delirium Requiring Sedation
Use dexmedetomidine rather than benzodiazepines when sedation is needed in delirious ICU patients (unless delirium is from alcohol/benzodiazepine withdrawal) 1, 2.
Recent high-quality evidence strongly supports this:
- The 4D trial (2025) showed dexmedetomidine significantly reduced agitation duration in non-intubated hyperactive delirious patients (median 1 vs 2 hours, p=0.001) 6
- The BaProDex trial (2025) found shorter delirium duration with overnight dexmedetomidine vs propofol (31 vs 66 hours in per-protocol analysis, HR 2.95, p=0.012) 7
- The 2025 SCCM update issued a conditional recommendation for dexmedetomidine over propofol for sedation 2
Dosing approach for dexmedetomidine:
- Start 0.2-0.7 mcg/kg/h IV infusion (no loading dose needed for delirium)
- Titrate to light sedation (RASS 0 to -2)
- Monitor for bradycardia and hypotension
Non-Pharmacologic Management (First-Line)
Prioritize these evidence-based interventions 1:
- Early mobilization - strongest recommendation (1B) to reduce delirium incidence and duration
- Sleep optimization - control light/noise, cluster care activities, minimize nighttime stimulation (1C)
- Avoid benzodiazepines - they are a risk factor for delirium development 1
- Maintain light sedation - target RASS 0 to -1 when sedation needed (1B)
- Analgesia-first approach - treat pain before sedating (2B)
Antipsychotics: Limited Role
Do NOT use haloperidol or atypical antipsychotics prophylactically (2C recommendation) 1. For treatment:
- No evidence haloperidol reduces delirium duration 1
- The MIND-USA trial (2018) showed neither haloperidol nor ziprasidone improved delirium outcomes vs placebo 3
- Withhold in patients with QTc prolongation or torsades risk (2C) 1
Clinical Algorithm for Hyperactive ICU Delirium
- Assess and treat reversible causes (hypoxia, infection, metabolic derangements, pain)
- Implement non-pharmacologic measures (mobilization, sleep hygiene, reorientation)
- If sedation required:
- Use dexmedetomidine 0.2-0.7 mcg/kg/h
- Avoid benzodiazepines (unless alcohol/benzodiazepine withdrawal)
- Target light sedation (RASS 0 to -2)
- Monitor with validated tools (CAM-ICU or ICDSC) at least 3x daily 1
- Avoid propranolol - no evidence, significant safety concerns
Key Pitfalls to Avoid
- Don't use beta-blockers for delirium - no evidence base and multiple contraindications in critical illness
- Don't prophylax with antipsychotics - ineffective and potentially harmful 1
- Don't use deep sedation - associated with worse outcomes; target light sedation 1
- Don't forget non-pharmacologic interventions - these have the strongest evidence for prevention 1